학술논문
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes
Document Type
Article
Author
Tian, J.; Chen, S.-J.; Li, J.; Mi, J.-Q.; Song, Y.-P.; Zhang, G.-C.; Wang, S.-F.; Chu, X.-X.; Chai, Y.; Wang, C.-L.; He, A.-L.; Zhang, F.; Shen, X.-L.; Zhang, W.-H.; Yang, L.-H.; Nie, D.-N.; Wang, D.-M.; Zhu, H.-L.; Gao, D.; Lou, S.-F.; Zhou, Z.-P.; Su, G.-H.; Li, Y.; Lin, J.-Y.; Shi, Q.-Z.; Ouyang, G.-F.; Jing, H.-M.
Source
In: Journal of Cancer Research and Clinical Oncology . (Journal of Cancer Research and Clinical Oncology, April 2024, 150(4))
Subject
Language
English
ISSN
14321335
01715216
01715216